1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atezolizumab in combination with obinutuzumab and lenalidomide demonstrates favorable activity and manageable toxicity in patients with relapsed/refractory follicular lymphoma (FL): An interim analysis of a phase Ib/II trial
    Meeting Abstract

    Salles, G.; Ghosh, N.; Lossos, I. S.; Palomba, M. L.; Mehta, A.; Casasnovas, O.; Stevens, D.; Abajo, A.; Nielsen, T.; Chitra, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Peripheral neuropathy is associated with an increased risk of fractures in individuals with monoclonal gammopathy of undetermined significance: A population-based study including 15,351 MGUS cases
    Meeting Abstract

    Rognvaldsson, S.; Thorsteinsdottir, S.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Blood (2018)

    Fulltext@MSK | Save
  • Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma
    Meeting Abstract

    Bachier Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H. J.; Giralt, S.
    Blood (2018)

    Fulltext@MSK | Save
  • Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant untreated AML: Results from a phase 1 dose escalation and expansion study
    Meeting Abstract

    Roboz, G. J.; DiNardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Donnellan, W. B.; Erba, H. P.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Survival for relapsed/refractory Hodgkin lymphoma patients with recurrent or persistent disease following autologous hematopoietic stem cell transplantation treated in the modern era
    Meeting Abstract

    Rajeeve, S.; Shah, G. L.; Moskowitz, C. H.; Moskowitz, A. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of combined ruxolitinib and thalidomide in patients with myelofibrosis: Initial results of a phase II study
    Meeting Abstract

    Rampal, R. K.; Verstovsek, S.; Devlin, S. M.; Stein, E. M.; Kadia, T. M.; Mauro, M. J.; Pemmaraju, N.; Alvarez, K.; Ard, N.; Goodman, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Asciminib, a specific allosteric BCR-ABL1 inhibitor, in patients with chronic myeloid leukemia carrying the T315I mutation in a phase 1 trial
    Meeting Abstract

    Rea, D.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Minami, H.; Breccia, M.; Deangelo, D. J.; Hochhaus, A.; Talpaz, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • OP-106 Horizon - Melflufen therapy for RRMM patients refractory to daratumumab and/or pomalidomide: Updated results and first report on PFS
    Meeting Abstract

    Richardson, P.; Ocio, E.; Oriol, A.; Larocca, A.; Otero, P. R.; Moreb, J.; Blade, J.; Hassoun, H.; Cavo, M.; Alegre, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation with haplo-identical CD34+ cells (haplo-dCBT) may speed neutrophil recovery although successful bridging is contingent on close haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Naputo, K.; Afuye, A. O.; Bhatt, V.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Blood (2018)

    Fulltext@MSK | Save